DoW Melanoma Research Program Idea Award
About
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding. Distinctive Features: • Preliminary data are discouraged. • After submitting the required pre-application, investigators must receive an invitation to submit a full application.
The DoW Melanoma Research Program (MRP) Idea Award is designed for researchers and innovators seeking to advance melanoma treatment and prevention through groundbreaking, exploratory research. This competitive grant program prioritizes novelty and innovation, making it ideal for investigators with bold, high-risk ideas that have the potential for significant impact in melanoma research. Unlike traditional grant programs that require extensive preliminary data, the Idea Award encourages researchers to pursue unconventional approaches and proof-of-concept studies. By the end of the funding period, successful projects are expected to establish proof of principle and generate preliminary data sufficient to secure follow-on funding from other sources. This program is particularly valuable for early-stage researchers, interdisciplinary teams, and established investigators looking to explore new research directions. If you have an innovative idea that could transform melanoma research but lack extensive preliminary findings, this award provides the financial support and institutional backing needed to validate your concept and launch a more comprehensive research initiative.
Funding Facts
● Applications openDeadline
October 14, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Not specified - contact program for details
Deadline
2026-10-14
Grant Type
federal
Application Cycle
Annual (Fiscal Year 2026 deadline: October 14, 2026); Two-stage pre-application and full application process
Best For
Melanoma researchers seeking to fund innovative, exploratory, high-risk research projects with significant potential impact
Frequently Asked Questions
Who is eligible for DoW Melanoma Research Program Idea Award?
Specific eligibility criteria are not provided in the available program information. For detailed eligibility requirements regarding institutional affiliation, researcher qualifications, and other restrictions, please visit the official Department of Defense Melanoma Research Program website or contact the program administrators directly.
How much funding does DoW Melanoma Research Program Idea Award provide?
Specific funding amounts are not listed in the current program information. Award amounts may vary by fiscal year and project scope. For current funding ranges and budget guidelines, visit the official DoD Melanoma Research Program website.
How do I apply for DoW Melanoma Research Program Idea Award?
The application process requires a two-stage approach. First, investigators must submit a pre-application. Following review, only selected applicants will receive an invitation to submit a full application. Detailed instructions, deadlines, submission portals, and required documentation are available on the official Department of Defense Melanoma Research Program website. Review all requirements carefully before beginning your pre-application.
What can DoW Melanoma Research Program Idea Award funding be used for?
This award supports innovative, exploratory melanoma research projects that are high-risk but potentially high-reward in nature. Funding is intended to support proof-of-concept studies and preliminary research that establishes feasibility for securing additional follow-on funding. The program emphasizes novel and innovative approaches. For specifics on allowable expenses and budget categories, consult the official program guidelines.
Last updated: July 5, 2026